Kidney Cancer Trial, Recruiting (NCT07141225)

Kidney Cancer Trial, Recruiting NCT07141225 Sponsor: Shao Pengfei Condition: Kidney Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT07141225 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Kidney Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged between 18 and 80 years old, of any gender
People whose scans show a kidney tumor measuring 7 cm or smaller
People whose imaging shows the tumor has not spread into the kidney's internal drainage system
People who are already scheduled to have a robot-assisted partial kidney removal surgery

Who may not be able to join:

People whose scans show the cancer has spread to other parts of the body or to nearby lymph nodes
People who have multiple tumors on one or both kidneys that cannot all be removed in a single surgery
People who have previously received systemic treatments such as targeted therapy, immunotherapy, or chemotherapy
People whose surgery changes during the procedure from a partial kidney removal to a full kidney removal
People whose surgery changes during the procedure from a robotic approach to open surgery

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Pengfei Shao, Professor, The First Affiliated Hospital of Nanjing Medical University (Jiangsu Provincial People's Hospital), Nanjing, Jiangsu 210036

Phone: +8613851925825

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07141225

Sponsor: Shao Pengfei

Phase: Not Applicable

Status: Recruiting

Condition: Kidney Cancer

Trial contact: +8613851925825

More information: https://clinicaltrials.gov/study/NCT07141225

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged between 18 and 80 years old, of any gender
People whose scans show a kidney tumor measuring 7 cm or smaller
People whose imaging shows the tumor has not spread into the kidney's internal drainage system
People who are already scheduled to have a robot-assisted partial kidney removal surgery

Who may not be able to join:

People whose scans show the cancer has spread to other parts of the body or to nearby lymph nodes
People who have multiple tumors on one or both kidneys that cannot all be removed in a single surgery
People who have previously received systemic treatments such as targeted therapy, immunotherapy, or chemotherapy
People whose surgery changes during the procedure from a partial kidney removal to a full kidney removal
People whose surgery changes during the procedure from a robotic approach to open surgery

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Shao Pengfei

Registry

ClinicalTrials.gov

Start date

1 June 2025

Est. completion

1 June 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Bilateral Kidney GFR

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov